Dechra Pharmaceuticals PLC/ GB0009633180 /
| 6/2/2023 5:29:43 PM | Chg. +280.00 | Volume | Bid5:30:00 PM | Ask5:39:26 PM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 3,641.00GBX | +8.33% | 1.59 mill. Turnover(GBP): 58.04 mill. |
-Bid Size: - | -Ask Size: - | 3.92 bill.GBP | - | - |
Assets
| 2015 IFRS in mill. GBP |
2016 IFRS in mill. GBP |
2017 IFRS in mill. GBP |
2018 IFRS in mill. GBP |
2019 IFRS in mill. GBP |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Property and Equipment | 16.8000 | 37.7000 | 45.2000 | 45.3000 | 58.4000 | ||||||
| Intangible Assets | 166.7000 | 360.4000 | 396.3000 | 709.8000 | 687 | ||||||
| Long-Term Investments | 0.0000 | 0.0000 | 10.9000 | 10.5000 | 10.1000 | ||||||
| Fixed Assets | - | - | - | - | - | ||||||
| Inventories | 31.7000 | 54.4000 | 56.5000 | 86.6000 | 104 | ||||||
| Accounts Receivable | 27.7000 | 59.2000 | 59.7000 | 81.6000 | 99.9000 | ||||||
| Cash and Cash Equivalents | 45.9000 | 39.1000 | 61.2000 | 79.7000 | 80.3000 | ||||||
| Current Assets | 108.6000 | 162.5000 | 185 | 247.9000 | 292.1000 | ||||||
| Total Assets | 292.1000 | 560.8000 | 638.1000 | 1,017.3000 | 1,048.5000 | ||||||
Liabilities
| 2015 IFRS in mill. GBP |
2016 IFRS in mill. GBP |
2017 IFRS in mill. GBP |
2018 IFRS in mill. GBP |
2019 IFRS in mill. GBP |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 10.4000 | 24.3000 | 21.4000 | 0.0000 | 0.0000 | ||||||
| Long-term debt | - | - | - | - | - | ||||||
| Liabilities to Banks | - | - | - | - | - | ||||||
| Provisions | 25 | 60.8000 | 55 | 105.5000 | 99.8000 | ||||||
| Liabilities | 97.6000 | 284.1000 | 335.4000 | 512.3000 | 539.4000 | ||||||
| Share Capital | .8800 | .9270 | .9320 | 1 | 1 | ||||||
| Total Equity | 194.5000 | 276.6000 | 302.6000 | 505 | 509.1000 | ||||||
| Minority Interests | 0.0000 | 2 | 1.6000 | 0.0000 | 0.0000 | ||||||
| Total liabilities equity | 292.1000 | 560.8000 | 638.1000 | 1,017.3000 | 1,048.5000 | ||||||
Income Statement
| 2015 IFRS in mill. GBP |
2016 IFRS in mill. GBP |
2017 IFRS in mill. GBP |
2018 IFRS in mill. GBP |
2019 IFRS in mill. GBP |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | 203.5000 | 247.6000 | 359.3000 | 407.1000 | 481.8000 | ||||||
| Depreciation (total) | - | - | - | - | - | ||||||
| Operating Result | 26 | 19.5000 | 33.2000 | 34.1000 | 39 | ||||||
| Interest Income | -.2000 | -4.9800 | -4.5000 | -4.9000 | -10.8000 | ||||||
| Income Before Taxes | 25.8000 | 14.5000 | 28.6000 | 28.9000 | 27.8000 | ||||||
| Income Taxes | 6.3000 | 2 | 2.5000 | -7.2000 | -3.1000 | ||||||
| Minority Interests Profit | 0.0000 | -.2000 | .0050 | 0.0000 | 0.0000 | ||||||
| Net Income | 19.5000 | 12.5000 | 26.1000 | 36.1000 | 30.9000 | ||||||
Per Share
Cash Flow
| 2015 IFRS in mill. GBP |
2016 IFRS in mill. GBP |
2017 IFRS in mill. GBP |
2018 IFRS in mill. GBP |
2019 IFRS in mill. GBP |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow from Operating Activities | 41 | 43.6000 | 77.4000 | 64 | 81.8000 | ||||||
| Cash Flow from Investing Activities | -4.7000 | -174 | -57.3000 | -241.7000 | -61.9000 | ||||||
| Cash Flow from Financing | -14.8000 | 125.3000 | 1.6000 | 193.8000 | -20.1000 | ||||||
| Decrease / Increase in Cash | -2.3000 | -5.1000 | 21.7000 | 16.1000 | -.2000 | ||||||
| Employees | 863 | 1,308 | 1,338 | 1,437 | 1,731 | ||||||